# Adding New Drugs for HIV Infected Patients Failing Current Therapy

> **NCT00031044** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 50 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Enfuvirtide
- **DRUG:** Amdoxovir

## Key facts

- **NCT ID:** NCT00031044
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2004-11
- **Target enrollment:** 50 (—)
- **Last updated:** 2021-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00031044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00031044, "Adding New Drugs for HIV Infected Patients Failing Current Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00031044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*